Palleos ensures realistic clinical trial planning through comprehensive feasibility analysis. Our experts conduct a multi-step process encompassing protocol and inclusion/exclusion criteria review, feasibility questionnaire development, patient population assessment, recruitment strategy creation, investigator and site experience analysis, and equipment/facility availability checks.
Secure swift and successful clinical trial approvals with Palleos. Our expert team navigates complex regulatory landscapes in Central and Eastern Europe, and exhibits extensive experience with FDA and EMA submissions, including pre-IND meetings, scientific advice, NDA applications, and orphan drug designations. We ensure your study documents receive the necessary approvals from all relevant authorities and ethics committees, facilitating smooth clinical trial processes.
Palleos’s country feasibility services provide a comprehensive assessment of the suitability of a specific country for your clinical trial. We evaluate factors such as regulatory landscape, healthcare infrastructure, patient population demographics, ethical review board accessibility, and potential recruitment challenges, ensuring you choose the optimal location for your study.
“At Palleos, our feasibility services save our sponsors both valuable time and resources. By providing a thorough assessment upfront, we avoid costly mistakes and ensure a clinical trial is designed for realistic and achievable success.”
Managing Director
